BIOLEX THERAPEUTICS, INC.

Profile

Company Names

BIOLEX THERAPEUTICS, INC.

Addresses

158 CREDLE STREET, PITTSBORO, NC 27312

Phone Numbers

(919) 542-9901

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$26,941,978.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2011-12-06 
$2,364,417.00 
$3,200,000.00 
$835,583.00 
Debt 
3
2011-05-27 
$5,899,709.00 
$6,675,000.00 
$775,291.00 
Debt 
2
2010-07-21 
$8,677,852.00 
$10,000,000.00 
$1,322,148.00 
Debt 
1
2010-02-11 
$10,000,000.00 
$10,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
W. 
THOMAS 
AMICK 
DIRECTOR
ALDAGEN INC   |  BIOLEX THERAPEUTICS, INC.
KEVIN 
 
BITTERMAN 
DIRECTOR
PARASOL THERAPEUTICS INC   |  TARIS BIOMEDICAL INC   |  BIOLEX THERAPEUTICS, INC.   |  FOLLICA, INC   |  VISTERRA, INC.   |  KALA PHARMACEUTICALS, INC.   |  GENOCEA BIOSCIENCES, INC.   |  NEURONETICS, INC.   |  DIRECT VET MARKETING, INC.   |  EDITAS MEDICINE, INC.   |  MORPHIC HOLDING, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  NAVITOR PHARMACEUTICALS, INC.   |  AKERO THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  KINASET THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  JUDO BIO INC.   |  CHROMA MEDICINE, INC.   |  REMIX THERAPEUTICS, INC.   |  GRO BIOSCIENCES INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  RENASANT BIO, INC.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
DAVID 
 
CASTALDI 
DIRECTOR
BIOLEX THERAPEUTICS, INC.   |  ADHERON THERAPEUTICS, INC.
DAVID 
L. 
CASTALDI 
DIRECTOR
BIOLEX THERAPEUTICS, INC.
DENNIS 
J. 
DOUGHERTY 
DIRECTOR
BIOLEX THERAPEUTICS, INC.
KURT 
 
GRAVES 
EXECUTIVE OFFICER, DIRECTOR
INTARCIA THERAPEUTICS, INC   |  BIOLEX THERAPEUTICS, INC.   |  SPRINGLEAF THERAPEUTICS, INC.   |  RADIUS HEALTH, INC.   |  PULMATRIX INC   |  PULMATRIX OPERATING COMPANY, INC.   |  PULMATRIX, INC.   |  I2O THERAPEUTICS, INC.
JEFF 
 
LEIDEN 
DIRECTOR
TYRX PHARMA INC   |  BIOLEX THERAPEUTICS, INC.   |  PATHAI, INC.
JEFFREY 
 
LEIDEN 
DIRECTOR
LYCERA CORP   |  CATABASIS PHARMACEUTICALS INC   |  TYRX PHARMA INC   |  BIOLEX THERAPEUTICS, INC.   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  CASANA CARE, INC.   |  ODYSSEY THERAPEUTICS, INC.
P. 
SHERRILL 
NEFF 
DIRECTOR
REGADO BIOSCIENCES INC   |  BIOLEX THERAPEUTICS, INC.   |  RAINDANCE TECHNOLOGIES INC   |  INTACT VASCULAR, INC.   |  NEURONETICS, INC.   |  VESPER MEDICAL, INC.   |  RAPID MICRO BIOSYSTEMS, INC.
LIZA 
PAGE 
NELSON 
DIRECTOR
BIOLEX THERAPEUTICS, INC.
LIZA 
 
PAGE NELSON 
DIRECTOR
BIOLEX THERAPEUTICS, INC.
DALE 
A. 
SANDER 
EXECUTIVE OFFICER
BIOLEX THERAPEUTICS, INC.   |  HUMACYTE, INC.
DAVID 
 
SPENCER 
EXECUTIVE OFFICER
BELLICUM PHARMACEUTICALS, INC   |  BIOLEX THERAPEUTICS, INC.
JAN 
P. 
TUREK 
EXECUTIVE OFFICER, DIRECTOR
BIOLEX THERAPEUTICS, INC.
KLAUS 
 
VEITINGER 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  BIOLEX THERAPEUTICS, INC.   |  RELYPSA INC   |  INTERCEPT PHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  TRICIDA, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  NEUROGASTRX, INC.   |  ALPHEUS MEDICAL, INC.
GLEN 
 
WILLIAMS 
EXECUTIVE OFFICER
BIOLEX THERAPEUTICS, INC.   |  MIDWEST INDEPENDENT BANCSHARES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-12-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-12-06 
2011-06-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-05-27 
2010-07-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-07-21 
2010-02-23
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-02-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#